Healwell AI Inc. (FRA:6H90)
Germany · Delayed Price · Currency is EUR 0.4960
-0.0110 (-2.17%)
At close: Jan 30, 2026
Healwell AI Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 97.64 | 38.97 | 7.32 | 10.42 | 47.82 | 38.57 | |
Revenue Growth (YoY) | 558.00% | 432.62% | -29.81% | -78.20% | 23.96% | -16.67% |
Cost of Revenue | 47.8 | 21.66 | 6.06 | 6.71 | 32.81 | 25.65 |
Gross Profit | 49.85 | 17.32 | 1.26 | 3.71 | 15.01 | 12.92 |
Selling, General & Admin | 56.63 | 45.71 | 14.04 | 13.78 | 33 | 16.86 |
Research & Development | 14.97 | 5.8 | 4.81 | 8.14 | 0.16 | - |
Operating Expenses | 87.37 | 51.5 | 18.85 | 21.92 | 33.15 | 16.86 |
Operating Income | -37.53 | -34.19 | -17.59 | -18.21 | -18.14 | -3.93 |
Interest Expense | -6.73 | -1.66 | -1.58 | -0.62 | -0.46 | -0.5 |
Interest & Investment Income | 0.41 | 0.64 | 0.24 | 0.02 | 0.11 | 0.06 |
Earnings From Equity Investments | - | - | - | -0.21 | - | - |
Other Non Operating Income (Expenses) | 0.78 | -1.9 | -0.42 | -0.04 | -0.1 | -0.09 |
EBT Excluding Unusual Items | -43.71 | -37.11 | -19.35 | -19.06 | -18.6 | -4.46 |
Impairment of Goodwill | -5.39 | -5.39 | -10.9 | - | - | - |
Gain (Loss) on Sale of Investments | 1.48 | 0.28 | -2.31 | -0.4 | - | - |
Asset Writedown | 0.85 | -0.23 | - | - | - | - |
Other Unusual Items | -0.17 | 13.53 | -0.9 | 1.64 | 1.64 | 2.97 |
Pretax Income | -48.94 | -28.28 | -32.68 | -17.08 | -16.29 | -1.34 |
Income Tax Expense | -0.69 | -0.86 | -0.54 | 1.12 | -0.75 | -0.31 |
Earnings From Continuing Operations | -48.25 | -27.43 | -32.14 | -18.2 | -15.54 | -1.03 |
Earnings From Discontinued Operations | -11.59 | -0.05 | 0.6 | -2.78 | - | - |
Net Income to Company | -59.84 | -27.48 | -31.55 | -20.97 | -15.54 | -1.03 |
Minority Interest in Earnings | 0.7 | 1.19 | -0.05 | -0.12 | -0.13 | -0 |
Net Income | -59.14 | -26.29 | -31.6 | -21.09 | -15.67 | -1.03 |
Net Income to Common | -59.14 | -26.29 | -31.6 | -21.09 | -15.67 | -1.03 |
Shares Outstanding (Basic) | 221 | 136 | 57 | 50 | 48 | 38 |
Shares Outstanding (Diluted) | 221 | 136 | 57 | 50 | 48 | 38 |
Shares Change (YoY) | 95.34% | 137.69% | 13.89% | 4.33% | 25.22% | 0.86% |
EPS (Basic) | -0.27 | -0.19 | -0.55 | -0.42 | -0.33 | -0.03 |
EPS (Diluted) | -0.27 | -0.19 | -0.55 | -0.42 | -0.33 | -0.03 |
Free Cash Flow | -24.09 | -22.71 | -10.86 | -8.64 | -7.93 | 4.14 |
Free Cash Flow Per Share | -0.11 | -0.17 | -0.19 | -0.17 | -0.17 | 0.11 |
Gross Margin | 51.05% | 44.43% | 17.18% | 35.59% | 31.39% | 33.51% |
Operating Margin | -38.43% | -87.72% | -240.43% | -174.68% | -37.94% | -10.19% |
Profit Margin | -60.57% | -67.47% | -431.83% | -202.27% | -32.77% | -2.67% |
Free Cash Flow Margin | -24.67% | -58.27% | -148.48% | -82.87% | -16.59% | 10.72% |
EBITDA | -33.48 | -32.06 | -16.11 | -16.73 | -17.05 | -3.46 |
EBITDA Margin | -34.29% | -82.25% | -220.21% | -160.45% | -35.66% | -8.97% |
D&A For EBITDA | 4.05 | 2.13 | 1.48 | 1.48 | 1.09 | 0.47 |
EBIT | -37.53 | -34.19 | -17.59 | -18.21 | -18.14 | -3.93 |
EBIT Margin | -38.43% | -87.72% | -240.43% | -174.68% | -37.94% | -10.19% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.